ArticleJournal of oncology2023

ARV-825 Showed Antitumor Activity against BRD4-NUT Fusion Protein by Targeting the BRD4.

Liu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.